Last reviewed · How we verify

Resveratrol Pill — Competitive Intelligence Brief

Resveratrol Pill (Resveratrol Pill) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Natural polyphenol / Sirtuin activator. Area: Cardiovascular, Metabolic health, Anti-aging.

marketed Natural polyphenol / Sirtuin activator SIRT1, antioxidant pathways, NF-κB Cardiovascular, Metabolic health, Anti-aging Small molecule Live · refreshed every 30 min

Target snapshot

Resveratrol Pill (Resveratrol Pill) — Russian Academy of Medical Sciences. Resveratrol is a polyphenolic compound that activates sirtuins and other cellular stress-response pathways to promote antioxidant and anti-inflammatory effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Resveratrol Pill TARGET Resveratrol Pill Russian Academy of Medical Sciences marketed Natural polyphenol / Sirtuin activator SIRT1, antioxidant pathways, NF-κB

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Natural polyphenol / Sirtuin activator class)

  1. Russian Academy of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Resveratrol Pill — Competitive Intelligence Brief. https://druglandscape.com/ci/resveratrol-pill. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: